Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.

Panero J, Stella F, Schutz N, Fantl DB, Slavutsky I.

PLoS One. 2015 Sep 14;10(9):e0137972. doi: 10.1371/journal.pone.0137972. eCollection 2015.

2.

Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression.

Panero J, Stanganelli C, Arbelbide J, Fantl DB, Kohan D, García Rivello H, Rabinovich GA, Slavutsky I.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):134-9. doi: 10.1016/j.bcmd.2013.10.002. Epub 2013 Nov 14.

PMID:
24239198
3.

Expression profile of telomere-associated genes in multiple myeloma.

Díaz de la Guardia R, Catalina P, Panero J, Elosua C, Pulgarin A, López MB, Ayllón V, Ligero G, Slavutsky I, Leone PE.

J Cell Mol Med. 2012 Dec;16(12):3009-21. doi: 10.1111/j.1582-4934.2012.01628.x.

4.

Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.

Panero J, Arbelbide J, Fantl DB, Rivello HG, Kohan D, Slavutsky I.

Mol Med. 2010 Nov-Dec;16(11-12):471-8. doi: 10.2119/molmed.2010.00057. Epub 2010 Jul 14.

5.

Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.

Kumar R, Khan R, Gupta N, Seth T, Sharma A, Kalaivani M, Sharma A.

Leuk Lymphoma. 2018 Jul;59(7):1677-1689. doi: 10.1080/10428194.2017.1387915. Epub 2017 Oct 18.

PMID:
29043869
6.

Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.

Kristensen IB, Christensen JH, Lyng MB, Møller MB, Pedersen L, Rasmussen LM, Ditzel HJ, Abildgaard N.

Br J Haematol. 2013 May;161(3):373-82. doi: 10.1111/bjh.12270. Epub 2013 Feb 22.

PMID:
23431957
7.

Cause-specific telomere factors deregulation in hepatocellular carcinoma.

El Idrissi M, Hervieu V, Merle P, Mortreux F, Wattel E.

J Exp Clin Cancer Res. 2013 Sep 11;32:64. doi: 10.1186/1756-9966-32-64.

8.

Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.

Poncet D, Belleville A, t'kint de Roodenbeke C, Roborel de Climens A, Ben Simon E, Merle-Beral H, Callet-Bauchu E, Salles G, Sabatier L, Delic J, Gilson E.

Blood. 2008 Feb 15;111(4):2388-91. Epub 2007 Dec 12.

PMID:
18077792
9.

Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.

Ci X, Li B, Ma X, Kong F, Zheng C, Björkholm M, Jia J, Xu D.

Oncotarget. 2015 Nov 10;6(35):38079-92. doi: 10.18632/oncotarget.5752.

10.

CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.

Carulli G, Buda G, Azzarà A, Ciancia EM, Sammuri P, Domenichini C, Guerri V, Petrini M.

Acta Haematol. 2016;135(1):11-4. doi: 10.1159/000380939. Epub 2015 Aug 15. No abstract available.

PMID:
26303094
11.

Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.

Kloth JK, Hillengass J, Listl K, Kilk K, Hielscher T, Landgren O, Delorme S, Goldschmidt H, Kauczor HU, Weber MA.

Int J Cancer. 2014 Nov 15;135(10):2380-6. doi: 10.1002/ijc.28877. Epub 2014 Apr 17.

12.

FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.

Korać P, Peran I, Skrtić A, Ajduković R, Kristo DR, Dominis M.

Pathol Int. 2009 May;59(5):354-8. doi: 10.1111/j.1440-1827.2009.02377.x.

PMID:
19432679
13.

Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.

Carrillo J, Calvete O, Pintado-Berninches L, Manguan-García C, Sevilla Navarro J, Arias-Salgado EG, Sastre L, Guenechea G, López Granados E, de Villartay JP, Revy P, Benitez J, Perona R.

Hum Mol Genet. 2017 May 15;26(10):1900-1914. doi: 10.1093/hmg/ddx098.

PMID:
28369633
14.

Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.

Andersen NF, Kristensen IB, Preiss BS, Christensen JH, Abildgaard N.

Eur J Haematol. 2015 Sep;95(3):211-7. doi: 10.1111/ejh.12473. Epub 2015 Jan 7.

PMID:
25353275
15.

MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).

Xiao R, Cerny J, Devitt K, Dresser K, Nath R, Ramanathan M, Rodig SJ, Chen BJ, Woda BA, Yu H.

Am J Surg Pathol. 2014 Jun;38(6):776-83. doi: 10.1097/PAS.0000000000000213.

PMID:
24705315
16.

Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.

Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A.

Liver Int. 2009 Sep;29(8):1162-70. doi: 10.1111/j.1478-3231.2009.02082.x. Epub 2009 Jul 17.

PMID:
19627485
17.

Nestin expression throughout multistep pathogenesis of multiple myeloma.

Svachova H, Kryukov F, Kryukova E, Sevcikova S, Nemec P, Greslikova H, Rihova L, Kubiczkova L, Hajek R.

Br J Haematol. 2014 Mar;164(5):701-9. doi: 10.1111/bjh.12689. Epub 2013 Dec 16.

PMID:
24329895
18.

Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.

Dos Santos PC, Panero J, Stanganelli C, Palau Nagore V, Stella F, Bezares R, Slavutsky I.

PLoS One. 2017 Jun 30;12(6):e0179883. doi: 10.1371/journal.pone.0179883. eCollection 2017.

19.

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR.

J Clin Oncol. 2004 May 15;22(10):1807-14.

PMID:
15143073
20.

Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.

Grass S, Preuss KD, Ahlgrimm M, Fadle N, Regitz E, Pfoehler C, Murawski N, Pfreundschuh M.

Lancet Oncol. 2009 Oct;10(10):950-6. doi: 10.1016/S1470-2045(09)70234-7. Epub 2009 Sep 18.

PMID:
19767238

Supplemental Content

Support Center